FDA inspection
Jubilant HollisterStier General Partnership: FDA inspection ending Nov 3, 2025
FDA inspection 1289886 · Official Action Indicated (OAI) · Kirkland
Key facts
| Inspection ID | 1289886 |
|---|---|
| Firm | Jubilant HollisterStier General Partnership |
| FEI number | 3001623073 |
| Address | 16751 Rte Transcanadienne |
| City | Kirkland |
| Country | Canada |
| Fiscal year | 2026 |
| Inspection end date | Nov 3, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 723537 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data